/EINPresswire.com/ -- SALT LAKE CITY, UT--(Marketwired - August 23, 2016) - InQpharm NA announced today that bmiSMART is one of five CPG product finalists selected for achievements in innovation and market impact in the weight loss category.

"InQpharm is proud to be one of the innovative ingredients showcased at SupplySide West. The patented ingredient complexes in bmiSMART's three products have exploded sales in the weight loss category across Europe and will do so in North America as well," said Dave Mastroianni, managing director InQpharm NA. "Our parent company, Zaluvida, spends millions of dollars on clinical research and testing so that we can deliver truly cutting-edge products that support healthy, sustainable weight loss in an effort to help battle global obesity."

The winner in the weight loss category will be announced at SupplySide West 2016 during the SupplySide CPG Editor's Choice Awards Presentations, set for October 6 and 7 at the Mandalay Bay Resort in Las Vegas, Nevada.

About bmiSMART
bmiSMART offers consumers an alternative approach to weight loss. The system includes three products, I-REMOVE Fat Binder (with scientifically studied and acclaimed LitramineÔ), I-BLOCK Carb & Sugar Blocker and I-CONTROL Appetite Reducer. bmiSMART weight wellness products are developed and manufactured by InQpharm, a global life sciences company that develops healthcare products rooted in nature and optimized through science. InQpharm delivers innovative solutions that nourish, protect, and improve lives in the consumer and animal health arenas. For more information please visit www.inqpharm.com.

Sharon Benedict
Director of Marketing Communications
InQpharm
801-824-8278
sbenedict@inqpharm.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.